374 related articles for article (PubMed ID: 6154440)
1. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions.
Itoyama Y; Sternberger NH; Webster HD; Quarles RH; Cohen SR; Richardson EP
Ann Neurol; 1980 Feb; 7(2):167-77. PubMed ID: 6154440
[TBL] [Abstract][Full Text] [Related]
2. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions.
Itoyama Y; Webster HD; Richardson EP; Trapp BD
Ann Neurol; 1983 Sep; 14(3):339-46. PubMed ID: 6195956
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical method to identify myelin basic protein in oligodendroglia and myelin sheaths of the human nervous system.
Itoyama Y; Sternberger NH; Kies MW; Cohen SR; Richardson EP; Webster H
Ann Neurol; 1980 Feb; 7(2):157-66. PubMed ID: 6154439
[TBL] [Abstract][Full Text] [Related]
4. Distribution of papovavirus, myelin-associated glycoprotein, and myelin basic protein in progressive multifocal leukoencephalopathy lesions.
Itoyama Y; Webster HD; Sternberger NH; Richardson EP; Walker DL; Quarles RH; Padgett BL
Ann Neurol; 1982 Apr; 11(4):396-407. PubMed ID: 6179456
[TBL] [Abstract][Full Text] [Related]
5. The distribution of myelin basic protein in central nervous system lesions of multiple sclerosis and acute experimental allergic encephalomyelitis.
Whitaker JN
Ann Neurol; 1978 Apr; 3(4):291-8. PubMed ID: 78682
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical study of myelin-associated glycoprotein (MAG) and basic protein (BP) in acute experimental allergic encephalomyelitis (EAE).
Itoyama Y; Webster HD
J Neuroimmunol; 1982 Dec; 3(4):351-64. PubMed ID: 6184382
[TBL] [Abstract][Full Text] [Related]
7. A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases.
Gendelman HE; Pezeshkpour GH; Pressman NJ; Wolinsky JS; Quarles RH; Dobersen MJ; Trapp BD; Kitt CA; Aksamit A; Johnson RT
Ann Neurol; 1985 Sep; 18(3):324-8. PubMed ID: 2413798
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical study of myelin-associated glycoprotein (MAG), basic protein (BP), and glial fibrillary acidic protein (GFAP) in chronic relapsing experimental allergic encephalomyelitis (EAE).
Webster HD; Shii H; Lassmann H
Acta Neuropathol; 1985; 65(3-4):177-89. PubMed ID: 2579517
[TBL] [Abstract][Full Text] [Related]
9. P2, P1, and P0 myelin protein expression in developing rat sixth nerve: a quantitative immunocytochemical study.
Hahn AF; Whitaker JN; Kachar B; Webster HD
J Comp Neurol; 1987 Jun; 260(4):501-12. PubMed ID: 2440915
[TBL] [Abstract][Full Text] [Related]
10. Successful immunocytochemical localization of myelin components in paraffin sections of human nervous tissue with preliminary observations on multiple sclerosis and metachromatic leukodystrophy lesions.
Itoyama Y; Sternberger N; Quarles R; Webster HD; Richardson EP; Cohen S; Moser HW
Trans Am Neurol Assoc; 1978; 103():216-9. PubMed ID: 92845
[No Abstract] [Full Text] [Related]
11. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
Wolswijk G; Balesar R
Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
[TBL] [Abstract][Full Text] [Related]
12. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
Mastronardi FG; Moscarello MA
J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
[TBL] [Abstract][Full Text] [Related]
13. Myelin-associated glycoprotein in multiple sclerosis lesions: a quantitative and qualitative analysis.
Möller JR; Yanagisawa K; Brady RO; Tourtellotte WW; Quarles RH
Ann Neurol; 1987 Oct; 22(4):469-74. PubMed ID: 2449119
[TBL] [Abstract][Full Text] [Related]
14. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
15. IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination.
Wilczak N; Chesik D; Hoekstra D; De Keyser J
Neurochem Int; 2008 Jun; 52(8):1431-5. PubMed ID: 18471934
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical study of P0 glycoprotein, P1 and P2 basic proteins, and myelin-associated glycoprotein (MAG) in lesions of idiopathic polyneuritis.
Schober R; Itoyama Y; Sternberger NH; Trapp BD; Richardson EP; Asbury AK; Quarles RH; Webster HD
Neuropathol Appl Neurobiol; 1981; 7(6):421-34. PubMed ID: 6173794
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
Prineas JW; Kwon EE; Goldenberg PZ; Ilyas AA; Quarles RH; Benjamins JA; Sprinkle TJ
Lab Invest; 1989 Nov; 61(5):489-503. PubMed ID: 2811298
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of the immunohistochemical localization of basic protein to myelin and oligodendrocytes in rat and chicken brain.
Hartman BK; Agrawal HC; Kalmbach S; Shearer WT
J Comp Neurol; 1979 Nov; 188(2):273-90. PubMed ID: 91628
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis: re-expression of a developmental gene in chronic lesions correlates with remyelination.
Capello E; Voskuhl RR; McFarland HF; Raine CS
Ann Neurol; 1997 Jun; 41(6):797-805. PubMed ID: 9189041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
